Busy Time for Dr. Forde; 1st Patent & a Prize!

25 November

veski innovation fellow, Dr. Gareth Forde is ‘over the moon’ over recent developments in his research work – and he believes that it is all due to veski's assistance in attracting him back to Australia.

Dr Forde excitement comes as he reveals his first patent or PCT on his ground breaking DNA Vaccine Purification Technology – to produce vaccines quicker, better, cheaper.

Dr Gareth Forde returned from Cambridge University to join the Monash University, Department of Chemical Engineering, Faculty of Engineering as a Lecturer with the veski innovation fellowship worth $200,000 over three years.

“This is the culmination of six years of blood, sweat and tears to develop this technology”, says Dr Forde, “and it’s a body of work that wouldn’t have been done without the support of veski.”

“The patent provides protection for the Intellectual Property (IP) in this area and allows us to look at a commercial joint development of the new technology.”

Dr Forde says three members of his research team have presented their work at the American Institute of Chemical Engineers Conference in UTAH this month (November). As well, Dr Forde has been honored with the Freehills Innovation Prize presented to a chemical engineer under the age of 40 who demonstrates full leadership.

And to top it off Dr Forde, his team of researchers and a consortium have been awarded an Australian Research Council “linkage” grant of just under $2 million to progress their work on the use of green algae to clean up carbon dioxide and create new fuels.

As Dr. Forde has completed his veski innovation fellowship we are delighted to announce that he will remain an ambassadorial veski fellow.

What's On

June

S M T W T F S
 
 
 
 
 
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 
11
 
12
 
13
 
14
 
15
 
16
 
17
 
18
 
19
 
20
 
21
 
22
 
23
 
24
 
25
 
26
 
27
 
28
 
29
 
30
 

What people say about veski

“Our research program is focused on working with industrial partners to develop novel therapeutics that will transform the treatment of chronic inflammatory diseases such as IBD.”

- Professor Colby Zaph

Tweets from @veskiorg